Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Optimata is a privately held bio-pharmaceutical company aiming at accelerating the long and costly process of drug development. Their innovative solution, Optimata Virtual Patient, is a biomathematics-based predictive software, enabling enhanced navigation of drug development towards a highly competitive market profile.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

BeBetter Med, Inc. engages in research and development of biopharmaceuticals. It focuses on treatment on tumors, autoimmune diseases, and metabolic diseases. The company was founded on January 19, 2012 and is headquartered in Guangzhou, China.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Medtronic MiniMed, Inc. manufactures insulin pumps and glucose monitoring systems. Its products include minimed 530g system, smartguard, enlite sensor, minimed revel and infusion sets. The company was founded by Alfred E. Mann in 1979 and is headquartered in Northridge, CA.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Attagene is a life science company, located in Research Triangle Park, NC, that has been transforming drug development and toxicity testing since 2001. Attagene has developed and patented a first-of-a-kind technology, FACTORIAL™ that enables high-content assessment of multiple gene regulatory pathways in live cells. A distinct feature of the FACTORIAL� platform is that it allows simultaneous assessment of multiple endpoints in a single well of cells, thereby eliminating intra-assay variations and producing robust and highly reproducible activity profiles.

Consiglio Nazionale delle Ricerche is the largest public research facility in Italy. Founded in 1923, it has worked in the past as a government consultant on research and as a funding fund for university research grants. Since 1989 the CNR is a research institution, with the mission of carrying out research projects, promoting innovation and competitiveness of the national industrial system, the internationalization of the national research system, and providing technologies and solutions to emerging needs in the public and private sectors. . Objectives that are achieved through a wealth of human resources that has over 8000 employees, half of which is represented by researchers and technologists. About 4,000 young researchers are involved in post-doctoral research activities in the laboratories of the Institute, while an important contribution comes from collaborations, including international ones, with researchers from universities and companies, thus strengthening the national research system.

Bergonie Institute is a cancer treatment center. They provide treatment for the spine, digestive system, genetics, gynecology, hematology, ENT, sarcomas, breast, the nervous system, thorax, thyroid, and urology. They also provide supportive oncological care and support that can be offered to a person suffering from a cancerous pathology. This includes specific treatments intended to cure their disease, such as chemotherapy, radiotherapy, and surgery.

Tech Mahindra is a global systems integrator and is a part of the Mahindra Group. Tech Mahindra represents the connected world, offering innovative and customer-centric information technology services and solutions, enabling Enterprises, Associates, and Society to Rise. They are a USD 4 billion company with 107,200+ professionals across 90 countries, helping over 818 global customers including Fortune 500 companies. Tech Mahindra is also amongst the Fab 50 companies in Asia as per the Forbes 2015 List.

Institute of Medical Information Technology engages in the development, maintenance and consulting of medical information systems.

Institut du Cerveau et de la Moelle ��pini��re is a French private company located in Paris. The firm engages in spinal cord and brain research and educational services. It was founded by Maurice L��vy and Serge Weinberg.

Chengdu Jianshu Technology Co., Ltd., established on 2018-05-21, Business scope includes licensed projects:Internet information service;Drug internet information service;Internet Information Service for Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Information system integration service;Data processing and storage support services;internet data service;Big data service;Artificial intelligence application software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;software development;Medical Research and Experimental Development;New material technology promotion service;Conference and Exhibition Services;Business Management Consulting;Digital Content Production Services(Does not include publishing);Educational Consulting Services(Education and training activities that do not include licensing approval);Advertising Design,acting;advertising(non-broadcasting station,television station,Newspaper Publishing Unit);translation service;Retailing of computer software, hardware and auxiliary equipment(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).